What Happens to the Immune Function When a Person Ages
Ann Am Thorac Soc. 2016 Dec; 13(Suppl 5): S422–S428.
Aging of the Immune System. Mechanisms and Therapeutic Targets
Received 2016 Feb 2; Accepted 2016 Apr 10.
Abstract
Beginning with the sixth decade of life, the human immune system undergoes dramatic crumbling-related changes, which continuously progress to a state of immunosenescence. The aging immune system loses the ability to protect against infections and cancer and fails to back up appropriate wound healing. Vaccine responses are typically impaired in older individuals. Conversely, inflammatory responses mediated by the innate immune organization gain in intensity and elapsing, rendering older individuals susceptible to tissue-damaging immunity and inflammatory illness. Immune system crumbling functions as an accelerator for other age-related pathologies. It occurs prematurely in some clinical conditions, most prominently in patients with the autoimmune syndrome rheumatoid arthritis (RA); and such patients serve as an informative model system to study molecular mechanisms of immune crumbling. T cells from patients with RA are prone to differentiate into proinflammatory effector cells, sustaining chronic-persistent inflammatory lesions in the joints and many other organ systems. RA T cells have several hallmarks of cellular crumbling; most chiefly, they accumulate damaged Deoxyribonucleic acid. Because of deficiency of the Dna repair kinase ataxia telangiectasia mutated, RA T cells carry a college burden of Dna double-strand breaks, triggering cell-indigenous stress signals that shift the prison cell's survival potential and differentiation pattern. Immune crumbling in RA T cells is also associated with metabolic reprogramming; specifically, with reduced glycolytic flux and diminished ATP production. Chronic energy stress affects the longevity and the functional differentiation of older T cells. Altered metabolic patterns provide opportunities to therapeutically target the immune aging process through metabolic interference.
Keywords: immune aging, T cells, inflammation, Deoxyribonucleic acid damage, glycolysis
Human being survival is closely linked to a functional allowed system, which protects the host against infections and malignancies, regulates wound healing, and ultimately separates "cocky" from surrounding organisms that compete for infinite and resource. The innate immune system provides fast and effective immune responses, but lacks discriminative power and long-term memory. The adaptive immune system functions by precise recognition of antigen, memory formation, and adaptive proliferation of those cells that provide antigen-specific immunity. T lymphocytes are the prison cell blazon with the highest proliferative potential in the body and with a survival span of several decades are subject to wear-and-tear harm.
At birth the immune system is equipped with an enormously diverse repertoire of antigen-reactive T and B cells, all of which are then infrequent that they cannot protect the host. Thus, as humans age and are exposed to infectious organisms and cancerous cells, antigen-specific lymphocytes need to aggrandize massively in frequency and switch from a highly proliferative naive cell into a less proliferative effector and memory cell. On antigen reappearance such effector/retentiveness cells take responsibleness for host protection through secretory products (e.one thousand., antibodies, cytokines) and jail cell-surface molecules (e.k., costimulatory and coinhibitory receptors and ligands). Massive clonal expansion and persistence of antigen-selected cells for decades impose enormous proliferative pressure on immune cells, rendering the immune arrangement highly susceptible to the aging procedure.
Crumbling is associated with several morbidities that finally lead to organ failure and death. With progressive deterioration of protective amnesty, older individuals get susceptible to cancers and infections (Table i). Interestingly, aging is also associated with increased incidence of inflammatory disease, most notably cardiovascular affliction (1). Many of the degenerative diseases of the elderly, such as Alzheimer'south disease, Parkinson's disease, and osteoarthritis, have a potent component of tissue-dissentious inflammation. Similarly, production of autoantibodies is much more than likely to occur in older individuals (2). In essence, allowed crumbling is associated with declining protective immunity combined with increasing incidence of inflammatory illness.
Table 1.
Cardinal features of immune organization aging
| Weakened antimicrobial immunity |
| • Susceptibility to respiratory infections |
| • Reactivation of chronic viral infections (due east.g., shingles) |
| Impaired antivaccine responses |
| Insufficient protection confronting malignancies |
| Predisposition for unopposed tissue inflammation |
| • Atherosclerotic disease |
| • Osteoarthritis |
| • Neurodegenerative affliction |
| Declining wound repair mechanisms |
Vice versa, it has been proposed that chronic organ diseases, such as chronic obstructive pulmonary illness and chronic kidney affliction, advance the crumbling process and thus lead to analogous phenotypes, such as musculus wasting, osteoporosis, and vascular aging (3). Acceleration of organismal crumbling due to failure of a major organ system, such every bit renal or respiratory impairment, has obvious implications for the cess and care of patients affected by chronic debilitating diseases. Whether acceleration of aging in chronic obstructive pulmonary affliction also has negative consequences for the immunocompetence of the host is not well understood (4, 5). Withal, predisposition to pulmonary infections is likely an accelerator for many chronic respiratory diseases, such as late-onset asthma, chronic obstructive pulmonary disease, and pulmonary fibrosis, identifying immunosenescence as a critical risk factor for respiratory disease.
Immunosenescence in Humans: Rheumatoid Arthritis as a Model Organisation
While the impact of aging on the innate allowed organisation remains insufficiently understood, much progress has been made in defining and characterizing molecular processes underlying the crumbling of T lymphocytes (6–8). T-jail cell crumbling progresses considerably faster in patients with a diagnosis of rheumatoid arthritis (RA), and investigation of such patients has enabled the definition of molecular pathways underlying T-cell immunosenescence (9–11) (Table two). Guiding observations were made almost xx years ago, when T cells in the synovial lesions of patients with RA were found to take a unique phenotype, CD4+CD28null (12, xiii). Loss of the costimulatory molecule CD28 is now recognized as a reliable aging marker on T cells (fourteen). Subsequent studies revealed that RA T cells accept shortening of telomeric sequences and that the telomeric loss affects naive, unprimed T cells equally well every bit bone marrow forerunner cells (15–19). Remarkably, salubrious individuals typing HLA-DR4, a MHC grade Ii haplotype associated with RA, share with patients the faster erosion of telomeres, already offset during the second to tertiary decades of life (16). These studies accept eliminated systemic inflammation as the root cause of premature immune aging and gave rise to the hypothesis that aged T cells may not be a consequence of RA, but a critical effector cell in the chronic inflammatory process (twenty).
Table 2.
T-prison cell aging in rheumatoid arthritis
| Accumulation of clonal CD4 T-cell populations that have lost expression of CD28 (CD4+CD28nil T cells) |
| Premature shortening of telomeres in |
| • Naive T cells |
| • Neutrophils |
| • CD34+ bone marrow precursor cells |
| Increased DNA breakage in CD4 T cells |
| Activation of the Dna repair response in CD4 T cells |
| Metabolic reprogramming of CD4 T cells |
| • Reduced glycolytic flux due to deficiency in PFKFB3 |
| • Reduced ATP production |
| • Enhanced shunting into the pentose phosphate pathway |
| • Backlog reductive elements (NADPH) and lack of reactive oxygen species |
Having RA is associated with the shortening of life expectancy, by and large due to acceleration of cardiovascular disease. CD4+CD28null T cells have likewise been isolated out of atherosclerotic plaque in patients with fatal myocardial infarction, implicating such cells in tissue inflammation (21, 22). CD4+CD28null T cells larn cytotoxic functions, brandish cytolytic activity toward endothelial cells, and produce loftier amounts of the proinflammatory cytokine IFN-γ (23–26).
Overall, a diagnosis of RA is associated with profound remodeling of the allowed organisation, including the accumulation of clonally expanded effector T cells that are proinflammatory and tissue subversive. While at that place remain unanswered questions about the "hen-and-egg" relationship of chronic autoimmune affliction and allowed crumbling (27), RA has emerged every bit an ideal model arrangement to study the molecular characteristics of pre-aged T cells.
Much of the progress made is in understanding the molecular pathways underlying T-prison cell aging in CD4 T cells. Curiously, CD8 T cells appear to age faster; the historic period-related loss of naive T cells is much more pronounced in the CD8 compared with the CD4 compartment. Concomitantly, cease-differentiated CD8 effector T cells expand to a college caste than their counterparts in the CD4 T-cell compartment (28, 29). Shorter telomeric lengths amid CD8 T cells compared with CD4 T cells support higher turnover in the CD8 compartment (30). Indeed, CD8 + CD28neg T cells are now recognized as a typical aging-related population. And then far, at that place is no evidence that fundamentally dissimilar processes are involved in aging CD4 and CD8 T cells. Several models have been proposed to explain why T cells in the same host may undergo differential aging. Such models include the speculation that CD4 and CD8 T cells live in distinct tissue niches, which are differentially susceptible to the affect of aging. An overall larger size of the CD4 compartment may be protective against the loss of naive cells. And, differences in cytokine responses maintaining homeostatic T-cell proliferation may ultimately impose higher proliferative pressure on CD8 T cells.
Deoxyribonucleic acid Harm and Immune Crumbling
A hallmark of the aging process is the shortening of chromosomal ends, due to the loss of telomeric sequence repeats (31). Human CD4 T cells lose near 3,000 bp of telomeric sequences between age 20 and age 60, when telomeric length reaches a plateau at a total length of five,000–6,000 bp. The curve correlating age and telomeric lengths in CD4 T cells is shifted toward college age in patients with RA with a 1,500-bp length reduction that is already evident in early on life (xv). Human being T cells practise not achieve telomeric crisis and those with telomeres shorter than five–6 kb appear to be culled long before the chromosomal ends are critically reduced. The mechanisms leading to prematurity of telomeric erosion in RA T cells are not understood. One cause lies in the dumb induction of telomerase activity in RA T cells (32). Telomerase activity in CD4 T cells is directly related to their survival and with reduced telomerase activity RA T cells are apoptosis sensitive. However, telomerase deficiency is bereft to provide an explanation for the premature uncapping of chromosomal ends in RA T cells. In vitro proliferation stress tests reveal that the loss of telomeric sequences is dependent on the differentiation condition of T cells, with telomerase-loftier naive T cells shedding many more telomeric repeats than their memory counterparts. Thus, failure in telomerase-contained protection mechanisms may be more relevant for T-cell aging (33).
Brusk telomeres represent a special instance of damaged Dna, and molecular studies in RA T cells have confirmed that DNA harm sensing and repair are fundamentally altered (Table 3). Specifically, measurements of Deoxyribonucleic acid breakage by comet assay (measuring the leakage of broken Dna from the nucleus) have yielded important insights into genome stability. RA T cells, even in patients who are only in the 3rd or fourth decade of life, have a high load of Deoxyribonucleic acid double-strand breaks (34). This affects naive besides every bit retentiveness CD4 T cells, is nowadays in untreated patients, and is barely amenable to antiinflammatory therapy. Screening for DNA repair molecules has demonstrated that the serine/threonine poly peptide kinase ataxia telangiectasia mutated (ATM) is comparatively expressed in RA T cells. Protein levels are reduced to about xl–50%. Overexpression of ATM in RA T cells corrects the defect and normalizes the Dna breakage load.
Table 3.
Dna damage in crumbling T cells
| Increased load of DNA double-strand breaks |
| Reduction in the protein levels of the repair kinase ATM |
| Lacking activation of p53-dependent pathways |
| Chronic activation of the repair kinase DNA-PKcs |
| DNA-PKcs–dependent triggering of the stress kinase JNK |
| Inappropriate loss of telomeric ends |
Interestingly, persistent Dna damage in such pre-aged T cells does not elicit consecration of p53. On the contrary, RA T cells are distinctly low in the apoptosis inducer p53 (34, 35). The tumor-suppressive office of p53 relates to its power to sense DNA harm and trigger protective measures, for instance, prison cell bike inhibition or promotion of apoptosis. Why RA T cells down-regulate p53 is not understood, simply signals multifaceted abnormalities in the surveillance of genome stability in cell cycle regulation.
Pre-aged T cells are not mute to the fact that their DNA is no longer every bit stable as in young T cells. Evidence derived from studies of culling DNA sensing and repair pathways indicates that older T cells are well aware of their precarious state of affairs. Indeed, RA T cells up-regulate DNA-dependent protein kinase, catalytic subunit (Dna-PKcs) (36), a member of the phosphatidylinositol-3-kinase–related kinase protein family and a close relative to ATM. DNA-PKcs is a principal component of the nonhomologous terminate-joining pathway of DNA repair. Mice born with mutated Dna-PKcs have a shorter life span and typically develop crumbling-related pathologies earlier in life (37). The prematurely anile T cells from patients with RA overexpress DNA-PKcs and its phosphorylated, active form. In a Dna-PKcs–dependent manner such T cells activate the stress kinase pathway via c-Jun Northward-last kinase (JNK). JNK has been implicated in regulating multiple fundamental cellular functions, such every bit jail cell growth, differentiation, survival, and apoptosis (38). Molecules regulated by JNK include c-Jun, ATF2, SMAD4, HSF1, ELK1, STAT3, and NFAT, which in immune cells are responsible for modulation of cytokine-induced, mitogen-activated protein kinase (MAPK), and transforming growth factor (TGF)-β–dependent signaling pathways. In essence, the inability to properly repair Dna initiates chronic stress signaling in crumbling T cells that has implications for nearly of their functional activities (Figure i).
Dna damage in rheumatoid arthritis (RA) T cells. Deficiency of the jail cell bicycle regulator and Deoxyribonucleic acid repair kinase ataxia telangiectasia mutated (ATM) changes the fate of T cells in patients with RA. ATMlo T cells featherbed the G2/M cell cycle checkpoint and insufficiently repair Dna double-strand breaks. One of the major consequences is excessive death of the T cells, perchance leading to lymphopenia, proliferative pressure to compensate for the loss, and thus premature aging. Dna-PKcs = DNA-dependent protein kinase, catalytic subunit.
Metabolic Reprogramming of Crumbling T Cells
The need to massively proliferate and to survive for decades imposes high demands on cellular free energy sources and requires admission to biosynthetic molecules as cell building blocks. To fulfill these needs, T cells switch their metabolic program to increased glucose utilization, well known as the Warburg effect (39). Glucose-intensive metabolism allows visualizing inflammatory T cells past positron emission tomography (PET) imaging. The energy needs of naive, memory, and effector T cells are fundamentally different, and studies deciphering energy regulation and the connection to functional parameters must be advisedly controlled for the limerick of young and onetime T-cell populations. Studies have emphasized that the metabolism of crumbling T cells is fundamentally dissimilar from their young counterparts (Table four). Naive CD4 T cells from patients with RA, pre-aged by about 20 years, generate lower amounts of lactate and ATP (forty), whereas the accumulation of NADPH is increased (41). The underlying molecular defect has been mapped to the imbalance of two enzymes regulating glucose utilization: half-dozen-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) and glucose-vi-phosphate dehydrogenase (G6PD) (41, 42). With decreased activity of PFKFB3 and enhanced action of G6PD, pyruvate product is disfavored. Such old T cells suffer from insufficient substrate to feed mitochondrial respiration and are energy deprived. Instead of breaking down glucose, they shunt information technology into the pentose phosphate pathway, promoting an anabolic state. One of the metabolic consequences is the accumulation of reductive elements, particularly NADPH and reduced glutathione, and the scavenging of reactive oxygen species. Overall, this shift in the metabolic program deprives onetime T cells from oxidant signaling. Multiple disquisitional functions of proliferating and differentiating T cells are dependent on oxidant signaling, leaving individuals with prematurely anile T cells with a functionally reprogrammed immune system (Effigy ii).
Table 4.
Metabolic reprogramming of aging T cells
| Energy deficiency acquired by insufficient ATP production |
| Reduced production of lactate |
| Dumb glycolytic breakdown due to insufficiency of the glycolytic enzyme PFKFB3 ("anti-Warburg effect") |
| Aggregating of reductive elements (NADPH) and reduced glutathione |
| Loss of activation-induced release of reactive oxygen species and weakening of oxidant signaling |
Metabolic reprogramming of prematurely anile T cells in rheumatoid arthritis (RA). Glucose imported into the jail cell can either be broken downwards to generate ATP or exist shunted into the pentose phosphate pathway (PPP) to generate reductive elements (NADPH). In RA T cells loftier action of glucose-6-phosphate dehydrogenase (G6PD) and low activity of phosphofructokinase (PFK) result in excessive shunting of glucose, leaving the cell under reductive stress and impairing redox signaling. As a consequence, such cells insufficiently activate the cell cycle regulator clutter telangiectasia mutated (ATM), which results in bypassing of the Gii/M phase, hyperproliferation, and a bias toward proinflammatory effector functions. ROS = reactive oxygen species.
Notably, PFKFB3 is too involved in inducing autophagy, and PFK-deficient RA T cells fail to rely on autophagy as a means of free energy generation (43, 44). The energy stress of aging T cells is aggravated by the asymmetric expression of the ATPase CD39 (45). Located on the cell membrane of CD4 T cells, CD39 activity critically controls the survival of effector T cells and their differentiation into long-lived memory T cells. In healthy older individuals, antigen-activated CD4 T cells overexpress this enzyme and become markedly apoptosis sensitive, resulting in poorer survival of effector T cells. This mechanism may be critically involved in curbing the induction of protective immune responses in such individuals, leaving them susceptible to infection and malignancy. Conversely, individuals with a genetic polymorphism in CD39 have improved antivaccine responses, emphasizing the function of the ATPase in controlling the pool of protective retentiveness T cells.
Chronic energy stress in onetime T cells has been implicated in other age-dependent immunodeficiencies. Specifically, free energy-deprived T cells upward-regulate activation of the energy sensor 5′-AMP–activated protein kinase (AMPK) (46). A downstream target of inappropriately activated AMPK in aging T cells is the dual-specificity poly peptide phosphatase 4 (DUSP4) (47), which negatively regulates members of the MAPK superfamily, in particular ERK1, ERK2, and JNK. ERK is besides subject to increased negative regulation past another dual-specificity protein phosphatase, DUSP6 (48). ERK is a fundamental regulator of the T-jail cell receptor signaling cascade, and its dephosphorylation by DUSP4 and DUSP6 functions as a suppressive mechanism, weakening the T-jail cell receptor–induced signal and dampening T-cell function. Old, DUSP4loftier T cells lose their power to provide helper function for antibody-forming B cells, thus undermining protective amnesty (47).
Conclusions
Crumbling of the immune arrangement is associated with dramatic changes in the distribution and competence of immune cells (49). The overriding theme is the loss of adaptive immunity and the proceeds of nonspecific innate amnesty, leaving older individuals susceptible to infection and cancer and unprotected from chronic tissue inflammation. The co-occurrence of weakened adaptive immunity with a bias toward nonspecific tissue inflammation is often captured in the term "inflammaging." Mechanisms fostering inflammatory illness in the old include the loss of immunoinhibitory chapters, specifically the deterioration of regulatory T-cell (Treg) part (50–52). Immune aging is a risk gene for and amplifies many of the pathologies associated with the aging process. Therapeutic interventions holding or reversing allowed aging would open opportunities to improve the direction of aging-related morbidities and have a major bear upon on the health status of club (53).
Key molecular pathways involved in T-cell aging have been identified (Figures 1 and 2). The diversity of the T-cell repertoire declines markedly, subtracting from the immune system's power to specifically recognize antigen (6, 54–56). A major defect in older T cells lies in the inability to properly repair damaged Dna (10, 57), which possibly extends to telomeric ends and identifies telomeric loss as a manifestation of historic period-related genomic instability. Central enzymes related to defective Dna repair in aging T cells include ATM and DNA-PKcs.
A mutual denominator of T-cell aging is chronic energy stress (eight, 58). Deficiency in the glycolytic enzyme PFKFB3 results in depression ATP levels. Dysregulated expression of the ATPase CD39 aggravates the lack of ATP product, rendering T cells apoptosis sensitive and the host deprived of sufficient T-prison cell expansion. Favoring of phosphatases over kinases in aging T cells emerges as a machinery elevating activation thresholds and resulting in low responsiveness (58). Antiaging therapy should aim at prolonging T-cell survival while weakening inflammation-decumbent innate immunity (7, 59).
Footnotes
Supported by the National Institutes of Wellness (R01 AR042547;, R01 AI044142;, HL 117913;, R01 AI108906;, and P01 HL058000 to C.Chiliad.Due west. and R01 AI108891, R01 AG045779, and I01 {"type":"entrez-nucleotide","attrs":{"text":"BX001669","term_id":"26186629","term_text":"BX001669"}}BX001669 to J.J.One thousand.), and the Govenar Discovery Fund. The authors declare no competing financial interests.
Writer disclosures are bachelor with the text of this article at world wide web.atsjournals.org.
References
i . Bansilal S, Castellano JM, Fuster V. Global burden of CVD: focus on secondary prevention of cardiovascular disease. Int J Cardiol. 2015;201:S1–S7. [PubMed] [Google Scholar]
two . Hurme G, Korkki S, Lehtimäki T, Karhunen PJ, Jylhä M, Hervonen A, Pertovaara K. Autoimmunity and longevity: presence of antinuclear antibodies is not associated with the rate of inflammation or mortality in nonagenarians. Mech Ageing Dev. 2007;128:407–408. [PubMed] [Google Scholar]
three . Kooman JP, Shiels PG, Stenvinkel P. Premature aging in chronic kidney disease and chronic obstructive pulmonary disease: similarities and differences. Curr Opin Clin Nutr Metab Care. 2015;xviii:528–534. [PubMed] [Google Scholar]
4 . Murray MA, Chotirmall SH. The impact of immunosenescence on pulmonary disease. Mediators Inflamm. 2015;2015:692546. [PMC gratuitous article] [PubMed] [Google Scholar]
5 . Johnstone J, Parsons R, Botelho F, Millar J, McNeil S, Fulop T, McElhaney J, Andrew MK, Walter SD, Devereaux PJ, et al. Immune biomarkers predictive of respiratory viral infection in elderly nursing home residents. PLoS One. 2014;9:e108481. [PMC free article] [PubMed] [Google Scholar]
6 . Goronzy JJ, Fang F, Cavanagh MM, Qi Q, Weyand CM. Naive T cell maintenance and function in homo aging. J Immunol. 2015;194:4073–4080. [PMC free article] [PubMed] [Google Scholar]
7 . Goronzy JJ, Weyand CM. Understanding immunosenescence to improve responses to vaccines. Nat Immunol. 2013;14:428–436. [PMC free article] [PubMed] [Google Scholar]
9 . Goronzy JJ, Shao L, Weyand CM. Immune crumbling and rheumatoid arthritis. Rheum Dis Clin North Am. 2010;36:297–310. [PMC free article] [PubMed] [Google Scholar]
10 . Goronzy JJ, Li G, Yang Z, Weyand CM. The Janus caput of T prison cell crumbling—autoimmunity and immunodeficiency. Forepart Immunol. 2013;iv:131. [PMC free article] [PubMed] [Google Scholar]
xi . Weyand CM, Yang Z, Goronzy JJ. T-cell aging in rheumatoid arthritis. Curr Opin Rheumatol. 2014;26:93–100. [PMC gratis commodity] [PubMed] [Google Scholar]
12 . Schmidt D, Goronzy JJ, Weyand CM. CD4+ CD7– CD28– T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest. 1996;97:2027–2037. [PMC free article] [PubMed] [Google Scholar]
13 . Warrington KJ, Takemura S, Goronzy JJ, Weyand CM. CD4+,CD28– T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. Arthritis Rheum. 2001;44:13–twenty. [PubMed] [Google Scholar]
14 . Broux B, Markovic-Plese Southward, Stinissen P, Hellings Northward. Pathogenic features of CD4+CD28– T cells in immune disorders. Trends Mol Med. 2012;18:446–453. [PubMed] [Google Scholar]
15 . Koetz K, Bryl E, Spickschen Thousand, O'Fallon WM, Goronzy JJ, Weyand CM. T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci USA. 2000;97:9203–9208. [PMC costless article] [PubMed] [Google Scholar]
16 . Schönland And so, Lopez C, Widmann T, Zimmer J, Bryl E, Goronzy JJ, Weyand CM. Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid prison cell lineages. Proc Natl Acad Sci U.s.. 2003;100:13471–13476. [PMC free article] [PubMed] [Google Scholar]
17 . Hohensinner PJ, Goronzy JJ, Weyand CM. Telomere dysfunction, autoimmunity and crumbling. Aging Dis. 2011;2:524–537. [PMC free article] [PubMed] [Google Scholar]
18 . Andrews NP, Fujii H, Goronzy JJ, Weyand CM. Telomeres and immunological diseases of aging. Gerontology. 2010;56:390–403. [PMC free commodity] [PubMed] [Google Scholar]
19 . Colmegna I, Diaz-Borjon A, Fujii H, Schaefer L, Goronzy JJ, Weyand CM. Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthritis Rheum. 2008;58:990–1000. [PMC free commodity] [PubMed] [Google Scholar]
twenty . Weyand CM, Fujii H, Shao L, Goronzy JJ. Rejuvenating the allowed organization in rheumatoid arthritis. Nat Rev Rheumatol. 2009;5:583–588. [PubMed] [Google Scholar]
21 . Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Frye RL, Weyand CM. Monoclonal T-prison cell proliferation and plaque instability in acute coronary syndromes. Circulation. 2000;101:2883–2888. [PubMed] [Google Scholar]
22 . Liuzzo G, Kopecky SL, Frye RL, O'Fallon WM, Maseri A, Goronzy JJ, Weyand CM. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation. 1999;100:2135–2139. [PubMed] [Google Scholar]
23 . Liuzzo G, Vallejo AN, Kopecky SL, Frye RL, Holmes DR, Goronzy JJ, Weyand CM. Molecular fingerprint of interferon-γ signaling in unstable angina. Apportionment. 2001;103:1509–1514. [PubMed] [Google Scholar]
24 . Nakajima T, Schulte Southward, Warrington KJ, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. T-cell–mediated lysis of endothelial cells in acute coronary syndromes. Circulation. 2002;105:570–575. [PubMed] [Google Scholar]
25 . Zhang Ten, Niessner A, Nakajima T, Ma-Krupa W, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. Interleukin 12 induces T-prison cell recruitment into the atherosclerotic plaque. Circ Res. 2006;98:524–531. [PubMed] [Google Scholar]
26 . Nakajima T, Goek O, Zhang X, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. De novo expression of killer immunoglobulin-similar receptors and signaling proteins regulates the cytotoxic part of CD4 T cells in acute coronary syndromes. Circ Res. 2003;93:106–113. [PubMed] [Google Scholar]
27 . Dehbi AZ, Radstake TR, Broen JC. Accelerated telomere shortening in rheumatic diseases: crusade or result? Skilful Rev Clin Immunol. 2013;9:1193–1204. [PubMed] [Google Scholar]
28 . Czesnikiewicz-Guzik K, Lee WW, Cui D, Hiruma Y, Lamar DL, Yang ZZ, Ouslander JG, Weyand CM, Goronzy JJ. T cell subset–specific susceptibility to aging. Clin Immunol. 2008;127:107–118. [PMC complimentary article] [PubMed] [Google Scholar]
29 . Wertheimer AM, Bennett MS, Park B, Uhrlaub JL, Martinez C, Pulko Five, Currier NL, Nikolich-Žugich D, Kaye J, Nikolich-Žugich J. Crumbling and cytomegalovirus infection differentially and jointly touch singled-out circulating T prison cell subsets in humans. J Immunol. 2014;192:2143–2155. [PMC free article] [PubMed] [Google Scholar]
30 . Son NH, Murray S, Yanovski J, Hodes RJ, Weng N. Lineage-specific telomere shortening and unaltered capacity for telomerase expression in homo T and B lymphocytes with age. J Immunol. 2000;165:1191–1196. [PubMed] [Google Scholar]
31 . Hodes RJ, Hathcock KS, Weng NP. Telomeres in T and B cells. Nat Rev Immunol. 2002;2:699–706. [PubMed] [Google Scholar]
32 . Fujii H, Shao L, Colmegna I, Goronzy JJ, Weyand CM. Telomerase insufficiency in rheumatoid arthritis. Proc Natl Acad Sci Us. 2009;106:4360–4365. [PMC costless article] [PubMed] [Google Scholar]
33 . Feuerhahn S, Chen LY, Luke B, Porro A. No DDRama at chromosome ends: TRF2 takes centre stage. Trends Biochem Sci. 2015;twoscore:275–285. [PubMed] [Google Scholar]
34 . Shao 50, Fujii H, Colmegna I, Oishi H, Goronzy JJ, Weyand CM. Deficiency of the Deoxyribonucleic acid repair enzyme ATM in rheumatoid arthritis. J Exp Med. 2009;206:1435–1449. [PMC gratuitous article] [PubMed] [Google Scholar]
35 . Maas Thou, Westfall 1000, Pietenpol J, Olsen NJ, Aune T. Reduced p53 in peripheral claret mononuclear cells from patients with rheumatoid arthritis is associated with loss of radiation-induced apoptosis. Arthritis Rheum. 2005;52:1047–1057. [PubMed] [Google Scholar]
36 . Shao Fifty, Goronzy JJ, Weyand CM. DNA-dependent poly peptide kinase catalytic subunit mediates T-cell loss in rheumatoid arthritis. EMBO Mol Med. 2010;ii:415–427. [PMC free article] [PubMed] [Google Scholar]
37 . Espejel S, Martín 1000, Klatt P, Martín-Caballero J, Flores JM, Blasco MA. Shorter telomeres, accelerated ageing and increased lymphoma in DNA-PKcs-deficient mice. EMBO Rep. 2004;5:503–509. [PMC free commodity] [PubMed] [Google Scholar]
38 . Kyriakis JM, Avruch J. Mammalian MAPK indicate transduction pathways activated past stress and inflammation: a 10-year update. Physiol Rev. 2012;92:689–737. [PubMed] [Google Scholar]
39 . Palmer CS, Ostrowski K, Balderson B, Christian Northward, Crowe SM. Glucose metabolism regulates T cell activation, differentiation, and functions. Forepart Immunol. 2015;6:1. [PMC free article] [PubMed] [Google Scholar]
twoscore . Yang Z, Matteson EL, Goronzy JJ, Weyand CM. T-cell metabolism in autoimmune disease. Arthritis Res Ther. 2015;17:29. [PMC free article] [PubMed] [Google Scholar]
41 . Yang Z, Shen Y, Oishi H, Matteson EL, Tian L, Goronzy JJ, Weyand CM. Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis. Sci Transl Med. 2016;8:331ra38. [PMC gratis article] [PubMed] [Google Scholar]
42 . Yang Z, Fujii H, Mohan SV, Goronzy JJ, Weyand CM. Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells. J Exp Med. 2013;210:2119–2134. [PMC free commodity] [PubMed] [Google Scholar]
43 . Collins RH, Lack 50, Killenberg PG. Rat hepatic bile acid sulfotransferase: enzyme response to androgens and estrogens. Am J Physiol. 1987;252:G276–G280. [PubMed] [Google Scholar]
44 . Yang Z, Goronzy JJ, Weyand CM. Autophagy in autoimmune disease. J Mol Med (Berl) 2015;93:707–717. [PMC free commodity] [PubMed] [Google Scholar]
45 . Fang F, Yu M, Cavanagh MM, Hutter Saunders J, Qi Q, Ye Z, Le Saux South, Sultan W, Turgano E, Dekker CL, et al. Expression of CD39 on activated T cells impairs their survival in older individuals. Cell Reports. 2016;14:1218–1231. [PMC free commodity] [PubMed] [Google Scholar]
46 . Selman C, Tullet JM, Wieser D, Irvine E, Lingard SJ, Choudhury AI, Blood M, Al-Qassab H, Carmignac D, Ramadani F, et al. Ribosomal protein S6 kinase one signaling regulates mammalian life bridge. Science. 2009;326:140–144. [PMC complimentary commodity] [PubMed] [Google Scholar]
47 . Yu Yard, Li G, Lee WW, Yuan Thou, Cui D, Weyand CM, Goronzy JJ. Signal inhibition by the dual-specific phosphatase four impairs T prison cell–dependent B-cell responses with historic period. Proc Natl Acad Sci United states. 2012;109:E879–E888. [PMC free commodity] [PubMed] [Google Scholar]
48 . Li G, Yu Thou, Lee WW, Tsang One thousand, Krishnan E, Weyand CM, Goronzy JJ. Decline in miR-181a expression with age impairs T cell receptor sensitivity past increasing DUSP6 activity. Nat Med. 2012;18:1518–1524. [PMC free commodity] [PubMed] [Google Scholar]
49 . Whiting CC, Siebert J, Newman AM, Du HW, Alizadeh AA, Goronzy J, Weyand CM, Krishnan E, Fathman CG, Maecker HT. Big-calibration and comprehensive immune profiling and functional assay of normal man crumbling. PLoS One. 2015;ten:e0133627. [PMC free article] [PubMed] [Google Scholar]
fifty . Jagger A, Shimojima Y, Goronzy JJ, Weyand CM. Regulatory T cells and the immune aging process: a mini-review. Gerontology. 2014;60:130–137. [PMC free article] [PubMed] [Google Scholar]
51 . Suzuki M, Jagger AL, Konya C, Shimojima Y, Pryshchep S, Goronzy JJ, Weyand CM. CD8+CD45RA+CCR7+FOXP3+ T cells with immunosuppressive properties: a novel subset of inducible human regulatory T cells. J Immunol. 2012;189:2118–2130. [PMC free article] [PubMed] [Google Scholar]
52 . Wen Z, Shimojima Y, Shirai T, Li Y, Ju J, Yang Z, Tian Fifty, Goronzy JJ, Weyand CM. NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs. J Clin Invest. 2016;126:1953–1967. [PMC gratuitous article] [PubMed] [Google Scholar]
53 . Olshansky SJ. Articulating the case for the longevity dividend. Common cold Bound Harb Perspect Med. 2016;6:a025940. [PMC gratuitous article] [PubMed] [Google Scholar]
54 . Goronzy JJ, Qi Q, Olshen RA, Weyand CM. High-throughput sequencing insights into T-cell receptor repertoire diversity in aging. Genome Med. 2015;7:117. [PMC complimentary article] [PubMed] [Google Scholar]
55 . Qi Q, Liu Y, Cheng Y, Glanville J, Zhang D, Lee JY, Olshen RA, Weyand CM, Boyd SD, Goronzy JJ. Diversity and clonal option in the human T-cell repertoire. Proc Natl Acad Sci Usa. 2014;111:13139–13144. [PMC free article] [PubMed] [Google Scholar]
56 . Qi Q, Zhang DW, Weyand CM, Goronzy JJ. Mechanisms shaping the naive T cell repertoire in the elderly: thymic involution or peripheral homeostatic proliferation? Exp Gerontol. 2014;54:71–74. [PMC gratuitous article] [PubMed] [Google Scholar]
57 . Cavanagh MM, Weyand CM, Goronzy JJ. Chronic inflammation and aging: DNA damage tips the balance. Curr Opin Immunol. 2012;24:488–493. [PMC free article] [PubMed] [Google Scholar]
58 . Goronzy JJ, Li One thousand, Yu M, Weyand CM. Signaling pathways in aged T cells: a reflection of T cell differentiation, cell senescence and host surround. Semin Immunol. 2012;24:365–372. [PMC free article] [PubMed] [Google Scholar]
59 . Hohensinner PJ, Goronzy JJ, Weyand CM. Targets of immune regeneration in rheumatoid arthritis. Mayo Clin Proc. 2014;89:563–575. [PMC free article] [PubMed] [Google Scholar]
Manufactures from Register of the American Thoracic Society are provided here courtesy of American Thoracic Society
Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291468/
0 Response to "What Happens to the Immune Function When a Person Ages"
Post a Comment